位置:成果数据库 > 期刊 > 期刊详情页
载长春西汀聚乙二醇-聚乳酸纳米粒在小鼠体内的药动学及组织分布
  • ISSN号:1007-7669
  • 期刊名称:《中国新药与临床杂志》
  • 时间:0
  • 分类:R944.9[医药卫生—药剂学;医药卫生—药学] R969.1[医药卫生—药理学;医药卫生—药学]
  • 作者机构:[1]曲靖医学高等专科学校药学系,云南曲靖655000, [2]大理学院药学与化学学院,云南大理671000, [3]复旦大学药学院,上海201203, [4]浦东医院,上海201399
  • 相关基金:国家自然科学基金(81072592)
中文摘要:

目的探讨载长春西汀聚乙Z-醇-聚乳酸纳米粒(Vin纳米粒)在小鼠体内的药动学及组织分布。方法48只ICR小鼠随机平均分成两组。每组分别尾静脉注射长春西汀注射液(Vin注射液)和Vin纳米粒,给药剂量均为5mg·kg^-1,于给药后不同时间摘眼球取血并制备各组织样品,采用蛋白沉淀法提取药物。建立液相色谱-串联质谱联用(LC-MS/MS)分析方法测定血浆及各组织Vin浓度,用DAS2.0药动学软件计算药动学参数。以重量-平均总靶向系数(TE*)和AUQ0-t为指标评价纳米粒的组织分布及靶向性。结果小鼠血浆中Vin纳米粒的AUC0-t是Vin注射液的165.4倍;t1/2由0.47h延长到2.71h,增加5.76倍;MRT0-t增加4.58倍。Vin纳米粒在脑中的滞留时间为注射液的2.24倍,t1/2为注射液的3.97倍,AUC0-t增加1.62倍。静脉注射Vin纳米粒后,对肝和脾靶向明显;在血浆、心、肝、脾、肺、肾和脑组织中,Vin纳米粒的AUQ-t均大于Vin注射液的AUQ0-t,Vin纳米粒的总AUQ0-t是Vin注射液的65.58倍。结论Vin纳米粒可延长在体内的循环时间,提高生物利用度。

英文摘要:

AIM To investigate pharmacokinetics and tissue distribution of polyethylene glycol- polylactide nanoparticles containing vinpocetine (Vin nanoparticles) in mice. METHODS Forty-eight ICR mice were randomly divided into two groups. These two groups were intravenously administered Vin nanoparticles and vinpocetine (Vin) commercial injection, respectively. The dosage was 5 mg·kg^-1. Eyeballs of mice were picked out to collect blood samples after intravenous injection and tissue homogenate of experimental animal was made immediately. Samples were prepared by protein precipitation using methanol. The concentrations of Vin in plasma and tissue homogenate were detected by LC- MS/MS method, and pharmacokinetic parameters were calculated with DAS 2.0 software program. The influence of Vin nanoparticle on tissue distribution was evaluated by targeting efficiency (TE*) and AUQ0-t. RESULTS In plasma, the AUC0-t of Vin nanoparticles was 165.4 times of Vin commercial injection, the t1/2 was prolonged from 0.47 h to 2.71 h, and the MRT0-t was 4.58 times of Vin commercial injection, respectively. The mean residence time, tu2 and AUC0-t of Vin nanoparticle in brain was 2.24, 3.79 and 1.62 times of Vin commercial injection. The highest distribution of Vin occurred in liver and spleen of Vin nanoparticle. In plasma, heart, liver, spleen, lung, kidney and brain, the AUQ0-t of Vin nanoparticle was greater than Vin commercial injection. The total AUQ0-t of Vin nanoparticle was 65.58 times that of Vin commercial injection. CONCLUSION It can be concluded that Vin nanoparticles had a long-circulating behavior and improved the bioavailability of Vin.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国新药与临床杂志》
  • 中国科技核心期刊
  • 主管单位:中国科学技术协会
  • 主办单位:中国药学会 上海市食品药品监督管理局科技情报研究所
  • 主编:陈凯先
  • 地址:上海柳州路615号
  • 邮编:200233
  • 邮箱:xyylc_tougao@126.com
  • 电话:021-64511836
  • 国际标准刊号:ISSN:1007-7669
  • 国内统一刊号:ISSN:31-1746/R
  • 邮发代号:4-347
  • 获奖情况:
  • 首届国家期刊奖,第2届全国、中国科协、上海市优秀科技期刊评比一等奖,第二届全国优秀科技期刊评比一等奖,上海市优秀科技期刊一等奖,第三届中国科协优秀科技期刊奖二等奖,中国期刊方阵双奖期刊
  • 国内外数据库收录:
  • 美国国际药学文摘,美国化学文摘(网络版),美国生物科学数据库,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:23434